Mitsuo Kaku

8.0k total citations
333 papers, 5.7k citations indexed

About

Mitsuo Kaku is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Mitsuo Kaku has authored 333 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 126 papers in Epidemiology, 115 papers in Infectious Diseases and 63 papers in Molecular Biology. Recurrent topics in Mitsuo Kaku's work include Antibiotic Resistance in Bacteria (46 papers), Pneumonia and Respiratory Infections (43 papers) and Antimicrobial Resistance in Staphylococcus (42 papers). Mitsuo Kaku is often cited by papers focused on Antibiotic Resistance in Bacteria (46 papers), Pneumonia and Respiratory Infections (43 papers) and Antimicrobial Resistance in Staphylococcus (42 papers). Mitsuo Kaku collaborates with scholars based in Japan, United States and Canada. Mitsuo Kaku's co-authors include Hironobu Koga, Yoichi Hirakata, S Kohno, Hideo Harigae, Shigeru Kohno, Tetsuji Aoyagi, Hiroyuki Kunishima, Takeshi Sasaki, Shigefumi Maesaki and Hiromu Takemura and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Mitsuo Kaku

321 papers receiving 5.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mitsuo Kaku 2.0k 1.8k 1.3k 900 757 333 5.7k
Katsunori Yanagihara 3.0k 1.5× 2.6k 1.4× 1.7k 1.3× 847 0.9× 985 1.3× 470 7.3k
Yoichi Hirakata 1.4k 0.7× 1.0k 0.6× 1.2k 0.9× 1.2k 1.4× 748 1.0× 204 4.5k
Satoshi Ichiyama 2.4k 1.2× 1.9k 1.1× 1.0k 0.8× 1.7k 1.9× 374 0.5× 217 5.8k
Catrin E. Moore 1.5k 0.7× 2.0k 1.1× 1.3k 1.0× 629 0.7× 483 0.6× 106 5.3k
Patrick R. Murray 2.9k 1.4× 2.3k 1.3× 1.9k 1.5× 718 0.8× 506 0.7× 198 9.1k
F. Espersen 1.7k 0.8× 2.1k 1.2× 1.2k 0.9× 460 0.5× 438 0.6× 189 5.3k
Eileen M. Burd 2.5k 1.2× 943 0.5× 1.5k 1.2× 1.0k 1.1× 682 0.9× 126 5.7k
R. Marre 2.4k 1.2× 1.2k 0.7× 1.6k 1.2× 854 0.9× 659 0.9× 175 6.4k
Elda Righi 1.7k 0.8× 1.7k 1.0× 1.0k 0.8× 1.5k 1.7× 674 0.9× 141 5.8k
Burke A. Cunha 2.1k 1.0× 1.5k 0.8× 803 0.6× 625 0.7× 321 0.4× 361 6.0k

Countries citing papers authored by Mitsuo Kaku

Since Specialization
Citations

This map shows the geographic impact of Mitsuo Kaku's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuo Kaku with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuo Kaku more than expected).

Fields of papers citing papers by Mitsuo Kaku

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuo Kaku. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuo Kaku. The network helps show where Mitsuo Kaku may publish in the future.

Co-authorship network of co-authors of Mitsuo Kaku

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuo Kaku. A scholar is included among the top collaborators of Mitsuo Kaku based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuo Kaku. Mitsuo Kaku is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Imai, Haruka, et al.. (2024). A retrospective observational study on disseminated herpes zoster in immunocompetent patients. Journal of Infection and Chemotherapy. 31(1). 102469–102469. 1 indexed citations
2.
Imai, Haruka, Jun Suzuki, Shota Takahashi, et al.. (2024). The Epidemiology of Circulating Respiratory Pathogens during the COVID-19 Pandemic. Internal Medicine. 63(12). 1683–1687. 2 indexed citations
3.
Suzuki, Jun, Shiro Endo, Shota Takahashi, et al.. (2022). Use of a multiplex polymerase chain reaction assay for the early detection of an outbreak of human parainfluenza virus type 3 infection in a nursery school during the COVID-19 pandemic. Infection Prevention in Practice. 4(3). 100221–100221. 2 indexed citations
4.
Imai, Haruka, Yuji Watanabe, Jun Suzuki, et al.. (2021). Utility of a Cell-Direct Polymerase Chain Reaction-Based Nucleic Acid Lateral Flow Immunoassay for Detection of Bacteria in Peripheral Blood Leukocytes of Suspected Sepsis Cases. Infection and Drug Resistance. Volume 14. 5137–5144. 2 indexed citations
6.
Ishii, Keiko, Yasushi Onishi, Noriko Fukuhara, et al.. (2017). Development and evaluation of a quantitative assay detecting cytomegalovirus transcripts for preemptive therapy in allogeneic hematopoietic stem cell transplant recipients. Journal of Medical Virology. 89(7). 1265–1273. 3 indexed citations
7.
Kudo, Daisuke, Tetsuji Aoyagi, Tomomitsu Miyasaka, et al.. (2017). Attenuated accumulation of regulatory T cells and reduced production of interleukin 10 lead to the exacerbation of tissue injury in a mouse model of acute respiratory distress syndrome. Microbiology and Immunology. 62(2). 111–123. 13 indexed citations
8.
Matono, Takashi, Takeshi Nishijima, Katsuji Teruya, et al.. (2017). Substantially Higher and Earlier Occurrence of Anti-Tuberculosis Drug-Related Adverse Reactions in HIV Coinfected Tuberculosis Patients: A Matched-Cohort Study. AIDS Patient Care and STDs. 31(11). 455–462. 9 indexed citations
9.
Endo, Shiro, et al.. (2016). Hand hygiene using a new hand-cleansing formulation without sanitizers: Effect on Staphylococcus aureus removal and recovery of properties against skin damage. American Journal of Infection Control. 44(8). e129–e132. 3 indexed citations
10.
Saito, Michiko, et al.. (2013). Antimicrobial susceptibilities of Clostridium difficile isolated in Japan. Journal of Infection and Chemotherapy. 19(2). 360–362. 16 indexed citations
11.
Endo, Shiro, Koichi Tokuda, Mochammad Hatta, et al.. (2012). . Japanese Journal of Infection Prevention and Control. 27(1). 50–56. 2 indexed citations
12.
Yamaguchi, Keizo, Yoshikazu Ishii, Yoshihisa Itoh, et al.. (2011). Antimicrobial activity of tazobactam/piperacillin against clinical isolates from 2001 to 2006 in Japan. 59(2). 177–187. 1 indexed citations
13.
Narita, Mitsuo, Norio Okazaki, Hitomi Ohya, et al.. (2008). S 3-6. Proposed antibiotic break points on Mycoplasma pneumoniae clinical isolates concerning macrolide and lincosamide antibiotics. 35. 59–60. 2 indexed citations
14.
Nakamura, Kiwamu, Akiko Miyazato, Gang Xiao, et al.. (2008). Deoxynucleic Acids from Cryptococcus neoformans Activate Myeloid Dendritic Cells via a TLR9-Dependent Pathway. The Journal of Immunology. 180(6). 4067–4074. 91 indexed citations
15.
Iwata, Satoshi, Hiromi Kumon, Yoshihito Niki, et al.. (2007). Survey on once-daily therapy with ceftriaxone for pediatric bacterial infections. 55(6). 463–472. 1 indexed citations
16.
Yoshida, Katsumi, et al.. (2003). [The Autonomic Nervous Activity in Patients with Essential Hypertension who Showed Early Morning Rise of Blood Pressure].. PubMed. 51(5). 414–8. 2 indexed citations
17.
Kobayashi, Ikuo, et al.. (2000). [Antibacterial activities of piperacillin in several fresh clinical isolates].. PubMed. 53(8). 573–81. 1 indexed citations
18.
Ishii, Keiko, Yuichi Takahashi, Mitsuo Kaku, & Takeshi Sasaki. (1999). Role of Human Parvovirus B19 in the Pathogenesis of Rheumatoid Arthritis. Japanese Journal of Infectious Diseases. 52(5). 201–207. 4 indexed citations
20.
Kawada, Yukimichi, Takashi Deguchi, Yoshio Aso, et al.. (1994). Dose-finding study on biapenem in complicated urinary tract infection. Chemotherapy. 42(10). 1114–1127. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026